Petros Pharmaceuticals, Inc. (PTPI) Annual Margin Report - Discounting Cash Flows
PTPI
Petros Pharmaceuticals, Inc.
PTPI (NASDAQ)

Annual Margin Analysis Report

Margins refer to the ratio between a financial report item and the revenue (Example: Net Income Margin = Net Income / Revenue).

This analysis provides a report of the company's key margins, which could be further used in a valuation model.

Interactive Assumptions

Historical Years

Historical Years

Number of historical years used to render the Chart and Tables.

Margin Analysis (% of Revenue)

Monetary values are in USD

amounts of USD except for #

Average LTM 2024 2023 2022 2021 2020
Revenue 6.34 3.72 5.11 5.82 5.99 7.81 9.56
Revenue Growth Rate -20.4% -27.17% -12.2% -2.83% -23.29% -18.29% -38.63%
Cost of Revenue 1.94 0.881 1.21 1.63 2.29 1.6 4.05
Gross Profit 4.39 2.84 3.9 4.19 3.7 6.21 5.51
Gross Margin 70.6% 76.34% 76.28% 71.98% 61.79% 79.52% 57.67%
Operating Income -16.28 -15.21 -17.68 -13.62 -15.85 -18.05 -17.28
Operating Margin -277.4% -408.5% -345.8% -233.9% -264.4% -231.1% -180.8%
Net Income -14.48 -14.42 -14.32 -8.16 -20.04 -9.36 -20.59
Net Margin -246.2% -387.2% -280.1% -140.2% -334.4% -119.8% -215.3%

amounts of USD except for #

Average LTM 2024 2023 2022 2021 2020
Revenue 6.34 3.72 5.11 5.82 5.99 7.81 9.56
Cash From Operating Activities Margin -131.2% -79.58% -50.92% -131% -213.6% -151.9% -160.1%
Cash From Operating Activities -8.86 -2.96 -2.6 -7.63 -12.8 -11.86 -15.31
Free Cash Flow Margin -131.4% -80.24% -51.4% -131% -213.6% -151.9% -160.2%
Free Cash Flow -8.87 -2.99 -2.63 -7.63 -12.8 -11.86 -15.31
Depreciation and Amortization Margin 71.04% 58.83% 57.58% 58.66% 93.44% 88.05% 69.67%
Depreciation and Amortization 4.61 2.19 2.94 3.42 5.6 6.88 6.66
Capital Expenditure Margin -0.396% -0.66% -0.481% 0% 0% 0% -0.048%
Capital Expenditure -0.018 -0.025 -0.025 0 0 0 -0.005
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us